Dyonmed SA., the first Greek company with POINT OF CARE tests and procedures, innovates again and introduces:
Immunity’s evaluation | Direct control | Suitable for population control
Immunity’s evaluation
Direct control
Suitable for population control
SARS-CoV-2 IgM/IgG Antibody Rapid Test Device (IMMUNOCHROMATOGRAPHY)
Detection of “passive” & “active” immunization.
The kit DyonCovid19-S® is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It is to be used as an aid in the diagnosis of coronavirus infection disease (COVID19), which is caused by SARS-CoV-2 (passive immunization).
The kit DyonCovid19-S ® is used to detect the “Neutralizing antibodies” (nAbs) of the specific spike (S) protein of the surface of SARS COV-2, helping significantly in the diagnosis of “active” immunization (after
vaccination).
INTENDED USE
It is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively.
PERFORMANCE CHARACTERISTICS
Find the patient profile you are interested in
Learn more about
Easy to use | High accuracy | Fast result
Find the patient profile you are interested in
Contact us for further information.
Customer service call center +31 210 6655494
